CHD

Business profile & competitive position

Church & Dwight Co., Inc. operates in the Consumer Defensive sector, specifically the Household & Personal Products industry. It develops, manufactures, and markets consumer household and personal care products, plus specialty products in animal nutrition, specialty chemicals, and commercial/professional cleaners. Recognizable names in its portfolio include ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA, and ZICAM. The company reports through three operating segments: Consumer Domestic, Consumer International, and Specialty Products Division.

The financial footprint supports a classic staples positioning. Net margin is 12.0% and ROE is 17.8%, both pointing toward meaningful brand pricing power and disciplined capital use.ROE in the high teens is well above the typical cost of equity for a low-risk consumer franchise, while double-digit margins suggest the portfolio can absorb commodity and promotional pressure without collapsing profitability. P/E of 32.1 implies the market already prizes that durability. A further marker of competitive strength is the company’s “power brands,” which represented approximately 70% of consolidated net sales and profits in 2025. That concentration means CHD’s economics ride on a small set of proven household names rather than on a diffuse lineup.

However, the profile also carries a concentration risk on the customer side: Walmart accounted for about 23% of consolidated net sales in 2025, and no other customer exceeded 10% over the preceding three years. Consumer Domestic sales in 2025 were split roughly 54% household products and 46% personal care. The implication is that CHD’s moat is built on brand equity and shelf presence, but its bargaining position with the largest U.S. retailer is a structural feature investors should monitor.

Financial posture

Church & Dwight currently has a market capitalization of $23.7 billion and trades on a P/E multiple of 32.1. That valuation is a clear premium to the broader market and to many slower-growth peers, so the stock is priced for steady execution rather than a turnaround. Net margin of 12.0% is healthy for a household-products business with constant promotional activity, and ROE of 17.8% confirms that management is generating a strong return on book equity.

Beta is just 0.47, which fits the Consumer Defensive label: the stock historically moves less than half as much as the overall market, making it a low-volatility holding by design. The combination of a low beta and a premium P/E means CHD is generally viewed as a “flight to quality” or recession-resistant name rather than a cyclical growth stock. Investors evaluating the shares need to weigh whether that 32.1 P/E is supported by continued margin stability and mid-single-digit volume growth from the power brands.

Strategic priorities & outlook

Church & Dwight’s most recent 10-K filing outlines a strategy built around portfolio upgrading, bolt-on integration, global expansion, and supply-chain resilience.

First, the company is repositioning the portfolio toward faster-growing value and premium product lines after exiting Flawless, Spinbrush, the Waterpik showerhead product, and the VMS brands. Those divestitures are intended to strip out slower or lower-margin businesses so resources can flow to higher-growth areas. Second, CHD is integrating the Touchland hand-sanitizer acquisition and expects it to contribute to both sales and earnings; this was a premium play in a category that sits adjacent to its personal care and household cleaning strengths.

Third, management wants to expand the seven power brands globally, citing their “potential for significant global expansion.” Because those brands already drive about 70% of revenue and profits, overseas growth is the most plausible path to outperforming a mature U.S. staples market. Fourth, supply-chain resilience is a stated priority: the company aims to maintain qualified dual sources for roughly 70% of direct materials spend. That target is directly relevant to a business exposed to commodities, packaging, and logistics costs.

Macro & geopolitical exposure

As a Household & Personal Products company, Church & Dwight faces macro pressures common to the industry. The most direct channel is input costs: resins, chemicals, paper and pulp, palm-oil derivatives, and transportation costs all influence gross margin. When those inputs move sharply, even a 12.0% net margin can compress unless pricing and productivity offsets keep pace.

Trade policy is another headline risk. Tariffs on imported materials or finished goods can raise costs, while retaliatory duties can complicate international expansion. A weaker or stronger dollar affects translation of Consumer International results, so currency is a recurring earnings variable. Regulation also matters in this sector: products are subject to FDA, FTC, and state-level oversight on labeling, safety, and advertising claims. Any product recall or adverse regulatory review can hit both sales and brand equity. Finally, high interest rates tend to put pressure on premium valuation multiples like CHD’s 32.1 P/E as investors demand higher returns from defensive assets, and the household-products category remains vulnerable to private-label substitution and consumer trade-down during periods of weak real wage growth.

Recent developments

August 31, 2026, brought a cluster of media attention. 247wallst.com included Church & Dwight in a list of “4 Battle-Tested Consumer Staples Stocks That Keep Raising Their Dividends,” framing it as a durable dividend-growth name. The same day, invezz.com reported that Bank of America named CHD among “3 stocks with meaningful upside in September,” while defenseworld.net disclosed that Corient Private Wealth LP had made a new investment in the company. Coverage this concentrated on a single date can amplify short-term sentiment but does not change the underlying fundamentals.

A few days earlier, on August 26, 2026, fool.com reported that a Church & Dwight EVP sold 15,375 shares for roughly $1.6 million. Insider selling alone is rarely decisive, and the filing does not indicate why the shares were sold, but it is worth noting alongside the institutional buying activity from Corient.

Earnings behavior & post-earnings drift

Over the last eight reported quarters, Church & Dwight has beaten earnings estimates six times, for a beat rate of 86%, with an average earnings surprise of 5.2%. The average five-day price move after those reports is +1.32%, classified as an “up” drift overall. That average suggests mild post-release appreciation, but the real story is more nuanced.

The most recent four quarters show a clear disconnect between the direction of the earnings surprise and the direction of the post-report drift. On July 31, 2026, CHD reported actual EPS of $0.89 versus an estimate of $0.896, a -0.7% miss, yet the stock rose 1.21% the next day and 4.48% over the following five days. By contrast, the May 1, 2026 quarter delivered a $0.95 EPS result against a $0.931 estimate, a 2.0% beat, but the stock fell 3.26% the next day and 2.69% over five days. The January 30, 2026 quarter produced a $0.86 actual versus $0.836 estimate, a 2.9% beat, with the stock rising 1.13% the next session and 4.45% over five days. The October 31, 2025 quarter was a much larger 10.1% beat ($0.81 vs. $0.736), yet the stock dropped 1.61% the next day and 0.95% over five days.

This pattern is exactly the kind of behavior that investors should examine carefully: an earnings beat has not reliably translated into a short-term upward drift for CHD, likely because expectations and valuation already embed a high bar. With the next report scheduled for October 30, 2026, before the open and the market's real expectation currently at $0.90 EPS, traders should focus on guidance and margin commentary rather than treating a simple beat or miss as mechanically bullish or bearish. The current snapshot has CHD at $100.08, with RSI at 48.8 and the 50-day EMA at $99.45, leaving the stock essentially in line with its near-term moving average heading into the next release.

For a deeper dive, readers should look at the full institutional verdict on CHD, including aggregated price targets, rating changes, and estimate-revision trends, rather than relying on any single earnings surprise or headline as a signal.